MedPath

A study on how caregivers can help their family members with schizophrenia to improve their cognitive functions

Not Applicable
Conditions
Health Condition 1: F20- Schizophrenia
Registration Number
CTRI/2023/03/050842
Lead Sponsor
Ajith S J
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

•Patients diagnosed with schizophrenia

•Education: 5 years and above

•Adequate visual and hearing ability

•Patient cooperative for assessment

Exclusion Criteria

1. History of substance dependence (other than nicotine dependence), epilepsy, traumatic brain injury, or other neurological disorders

2. Co-morbid intellectual disability based on case records/ History of developmental delays

3. Currently undergoing or had undergone any form of cognitive remediation in the last six months

4. Received electro-convulsive therapy in the last three months

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The study is intended to assess the effect of cognitive remediation on cognitive functions (such as attention and memory) measured through neuropsychological assessment and EEG-based event-related potentials. Therefore, the primary outcome variable is change in neurocognitive functions due to cognitive remediation carried out in patientâ??s home setting with the help of a caregiver.Timepoint: The patients will be evaluated at three levels pre-intervention, post-intervention, and a follow-up (after 8 weeks post-intervention).
Secondary Outcome Measures
NameTimeMethod
ILTimepoint: NI
© Copyright 2025. All Rights Reserved by MedPath